J Am Acad Dermatol:临床医生应警惕——贝赛特氏症的癌症风险较高

2017-10-31 MedSci MedSci原创

背景:贝赛特氏症(Behçet's disease),是一种自体免疫疾病,又名白塞病(Betch’s disease,BD)是一种全身慢性疾病,基本病理改变为血管炎。临床以复发性口腔溃疡、生殖器溃疡、皮肤和眼部病变最为常见,但全身各脏器均可受累。先前的许多研究表明炎症与癌症的发展之间存在联系。然而,很少有研究探讨贝赛特氏症和癌症之间的相关性。目标:本研究旨在确定贝赛特氏症患者

背景:贝赛特氏症(Behçet's disease),是一种自体免疫疾病,又名白塞病(Betch’s disease,BD)是一种全身慢性疾病,基本病理改变为血管炎。临床以复发性口腔溃疡、生殖器溃疡、皮肤和眼部病变最为常见,但全身各脏器均可受累。

先前的许多研究表明炎症与癌症的发展之间存在联系。然而,很少有研究探讨贝赛特氏症和癌症之间的相关性。

目标:本研究旨在确定贝赛特氏症患者的总体癌症风险和一些特定癌症的风险。

方法:研究人员使用韩国国民健康保险数据库的数据,选择2007-2014年间确诊的没有癌症的BD患者(n=14137;平均年龄,44.2 - 12.5岁;男性,32.4%)。使用随机抽样,以1:10的比例按年龄和性别匹配无BD的健康患者。研究人员分别对这两个队列随访癌症发生率,直到2015年。

结果:总体而言,在随访期间,451名(3.19%)BD患者和3975名(2.81%)对照者被诊断为癌症。与对照者相比,BD患者表现出显著较高的患癌风险(风险比[HR]=1.13[1.03-1.25]),特别是白血病(HR =5.80[ 3.24-10.39])、淋巴瘤(HR=2.58[1.56-4.28])、口咽癌(HR=2.11[1.02-4.05])、甲状腺癌(HR= 1.26[1.05-1.50])、前列腺癌(HR = 1.78[1.14-2.79])。

局限性:对每个患者的治疗或严重程度未作明确确定。

结论:与非贝赛特氏症者相比,贝赛特氏症患者的总体癌症风险更高。临床医生应仔细监测BD患者恶性肿瘤的潜在发展。

原始出处:

Na SJ, Kang MJ,et al.Cancer risk in patients with Behçet's disease: A nationwide population-based dynamic cohort study from Korea.J Am Acad Dermatol. 2017 Sep 25. pii: S0190-9622(17)32440-4. doi: 10.1016/j.jaad.2017.09.035. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1651899, encodeId=aaff165189907, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Oct 11 00:55:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554778, encodeId=d2521554e782c, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Nov 02 12:55:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257900, encodeId=d22a25e90021, content=不错的文章值得一读, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Nov 01 23:14:29 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257638, encodeId=874625e63840, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Nov 01 00:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=)]
    2018-10-11 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1651899, encodeId=aaff165189907, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Oct 11 00:55:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554778, encodeId=d2521554e782c, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Nov 02 12:55:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257900, encodeId=d22a25e90021, content=不错的文章值得一读, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Nov 01 23:14:29 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257638, encodeId=874625e63840, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Nov 01 00:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1651899, encodeId=aaff165189907, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Oct 11 00:55:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554778, encodeId=d2521554e782c, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Nov 02 12:55:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257900, encodeId=d22a25e90021, content=不错的文章值得一读, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Nov 01 23:14:29 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257638, encodeId=874625e63840, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Nov 01 00:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=)]
    2017-11-01 1e1b8538m79(暂无匿称)

    不错的文章值得一读

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1651899, encodeId=aaff165189907, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1795, encryptionId=3a3e1e9504, topicName=ACA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843c24278901, createdName=lishizhe, createdTime=Thu Oct 11 00:55:00 CST 2018, time=2018-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554778, encodeId=d2521554e782c, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Nov 02 12:55:00 CST 2017, time=2017-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257900, encodeId=d22a25e90021, content=不错的文章值得一读, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Nov 01 23:14:29 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257638, encodeId=874625e63840, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Wed Nov 01 00:21:00 CST 2017, time=2017-11-01, status=1, ipAttribution=)]
    2017-11-01 飛歌

    厉害了我的哥

    0

相关资讯

Nucleic Acids Res+Nat Commun:艾滋病毒可以成功治愈癌症?是“天方夜谭”还是“有据可循”

来自加拿大的研究员Linda Chelico等表示:“我们的发现可能会改变治疗癌症的方式。”《Nucleic Acids Res》和《Nat Commun》刊登了她的最新研究成果。

美国癌症患者何弃疗?

一项新的调查揭示了导致27%的美国癌症患者无奈放弃部分治疗的原因。

J Clin Oncol:年轻癌症幸存者中HPV疫苗接种率调查

处于青少年或青年期的癌症幸存者因接受过抗肿瘤治疗,可能面临免疫功能下降,此外,这一年龄群体处于性活跃,因此,感染HPV的风险较高。近期,JCO发布的一项研究,调查了年轻癌症幸存者中HPV疫苗接种率,发现这类人群的HPV接种率较同年龄大众群体低,值得引发关注。

JAMA Oncol:靶向抗癌药究竟对哪些癌症患者有效,一测便知!

癌症药物帕尼单抗是晚期肠癌患者的一种选择,然而这种靶向药只对一部分患者有效果,对于其他患者而言,这种靶向药不仅无法改善病情,而且还会带来难以忍受的副作用。

Int J Cancer:生活在核电站附近的成年人的癌症发病率研究

在对法国NPP附近生活的成年人的第一次癌症发生风险研究中发现:膀胱癌发生风险明显高于参考群体。

1/3癌症可治愈!心态是理想的抗癌神器

如果尽早发现并积极治疗,1/3癌症是可以被治愈的。